|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 750 9th Street, NW |
Address2 | SUITE 500 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 17933-00012
|
||||||||
|
6. House ID# 312630000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: DAVID WIERMANSKI |
Date | 7/5/2017 1:30:15 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 2938 Removing Barriers to Medicaid and CHIP Addiction Treatment Act of 2017
H. Res. 142 Expressing support for "National Obesity Care Week"
S. Res. 63 Expressing support for "National Obesity Care Week"
H.R. 181 Close Annuity Loopholes in Medicaid Act
H.R. 184 Protect Medical Innovation Act
H.R. 244 Consolidated Appropriations Act, 2017
H.R. 284 Advancing Medical Resident Training in Community Hospitals Act
H.R. 309 National Clinical Care Commission Act
S. 920 National Clinical Care Commission Act
H.R. 372 Competitive Health Insurance Reform Act
H.R. 592 Pharmacy and Medically Underserved Areas Enhancement Act
S. 109 Pharmacy and Medically Underserved Areas Enhancement Act
H.R. 706 Plan Verification and Fairness Act
H.R. 741 Rural Hospital Regulatory Relief Act
S. 243 Rural Hospital Regulatory Relief Act
H.R. 749 Lower Drug Costs through Competition Act
H.R. 766 Amend Title XVII of the Social Security Act to Expand Telehealth in Medicare
H.R. 829 Prioritizing the Most Vulnerable Over Lottery Winners Act
H.R. 849 Protecting Seniors' Access to Medicare Act
S. 260 Protecting Seniors' Access to Medicare Act
H.R. 908 Medicare Advantage Quality Payment Relief Act
H.R. 998 Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act
H.R. 1004 Regulatory Integrity Act
H.R. 1009 OIRA Insight, Reform, and Accountability Act
S. 676 OIRA Insight, Reform, and Accountability Act
H.R. 1038 Improving Transparency and Accuracy in Medicare Part D Spending
H.R. 1072 Obamacare Replacement Act
S. 222 Obamacare Replacement Act
H.R. 1101 Small Business Health Fairness Act
H.R. 1121 Pre-Existing Conditions Protection Act
H.R. 1148 Furthering Access to Stroke Telemedicine (FAST) Act
S. 431 Furthering Access to Stroke Telemedicine (FAST) Act
H.R. 1215 Protecting Access to Care Act
H.R. 1245 Affordable and Safe Prescription Drug Importation Act
S. 469 Affordable and Safe Prescription Drug Importation Act
H.R. 1267 Personal Health Investment Today (PHIT) Act
S. 482 Personal Health Investment Today (PHIT) Act
H.R. 1304 Self-Insurance Protection Act
H.R. 1313 Preserving Employee Wellness Programs Act
H.R. 1554 Jessie's Law
S. 581 Jessie's Law
H.R. 1565 Saving Lives, Saving Costs Act
H.R. 1628 American Health Care Act
H.R. 1703 Medical Product Communications Act
H.R. 1776 Improving Access to Affordable Prescription Drugs Act
S. 771 Improving Access to Affordable Prescription Drugs Act
H.R. 1922 Foreign Medical School Accountability Fairness Act
S. 850 Foreign Medical School Accountability Fairness Act
H.R. 1953 Treat and Reduce Obesity Act (TROA)
S. 830 Treat and Reduce Obesity Act (TROA)
H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act
S. 898 Conrad State 30 and Physician Access Reauthorization Act
H.R. 2192 To Amend the Public Health Service Act to Eliminate the Non-Application of Certain State Waiver Provisions to Members of Congress and Congressional Staff
H.R. 2212 Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act
S. 974 Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act
H.R. 2267 Resident Physician Reduction Shortage Act
H.R. 246 Jobs and Premium Protection Act
H.R. 2550 Medicare Telehealth Parity Act
H.R. 2556 CONNECT for Health Act
S. 1016 CONNECT for Health Act
H.R. 2953 Amend the Congressional Budget Act of 1974 Respecting the Scoring of Preventive Health Savings
S. 108 Medical Device Access and Innovation Protection Act
S. 183 Jobs and Premium Protection Act
S. 191 Patient Freedom Act
S. 251 Protecting Medicare from Executive Action Act
S. 309 Community-Based Independence for Seniors Act
S. 413 Improving Transparency and Accuracy in Medicare Part D Spending
S. 464 Independence at Home Act
S. 469 Affordable and Safe Prescription Drug Importation Act
S. 64 Safe and Affordable Drugs from Canada Act
S. 761 Health Care Options Act
S. 771 Improving Access to Affordable Prescription Drugs Act
S. 787, Telehealth Innovation and Improvement Act
S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Grealy |
|
|
|
Debbie |
Witchey |
|
|
|
Michael |
Freeman |
|
|
|
Tina |
Grande |
|
|
|
Amanda |
Uherek |
|
|
|
Christopher |
Adamec |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2938 Removing Barriers to Medicaid and CHIP Addiction Treatment Act of 2017
H.R. 181 Close Annuity Loopholes in Medicaid Act
H.R. 184 Protect Medical Innovation Act
H.R. 244 Consolidated Appropriations Act, 2017
H.R. 284 Advancing Medical Resident Training in Community Hospitals Act
H.R. 372 Competitive Health Insurance Reform Act
H.R. 592 Pharmacy and Medically Underserved Areas Enhancement Act
S. 109 Pharmacy and Medically Underserved Areas Enhancement Act
H.R. 741 Rural Hospital Regulatory Relief Act
S. 243 Rural Hospital Regulatory Relief Act
H.R. 749 Lower Drug Costs through Competition Act
H.R. 766 Amend Title XVII of the Social Security Act to Expand Telehealth in Medicare
H.R. 829 Prioritizing the Most Vulnerable Over Lottery Winners Act
H.R. 849 Protecting Seniors' Access to Medicare Act
S. 260 Protecting Seniors' Access to Medicare Act
H.R. 908 Medicare Advantage Quality Payment Relief Act
H.R. 998 Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act
H.R. 1004 Regulatory Integrity Act
H.R. 1038 Improving Transparency and Accuracy in Medicare Part D Spending
H.R. 1072 Obamacare Replacement Act
S. 222 Obamacare Replacement Act
H.R. 1148 Furthering Access to Stroke Telemedicine (FAST) Act
S. 431 Furthering Access to Stroke Telemedicine (FAST) Act
H.R. 1245 Affordable and Safe Prescription Drug Importation Act
S. 469 Affordable and Safe Prescription Drug Importation Act
H.R. 1565 Saving Lives, Saving Costs Act
H.R. 1628 American Health Care Act
H.R. 1703 Medical Product Communications Act
H.R. 1776 Improving Access to Affordable Prescription Drugs Act
S. 771 Improving Access to Affordable Prescription Drugs Act
H.R. 2550 Medicare Telehealth Parity Act
H.R. 2556 CONNECT for Health Act
S. 1016 CONNECT for Health Act
S. 108 Medical Device Access and Innovation Protection Act
S. 251 Protecting Medicare from Executive Action Act
S. 309 Community-Based Independence for Seniors Act
S. 413 Improving Transparency and Accuracy in Medicare Part D Spending
S. 464 Independence at Home Act
S. 469 Affordable and Safe Prescription Drug Importation Act
S. 64 Safe and Affordable Drugs from Canada Act
S. 761 Health Care Options Act
S. 771 Improving Access to Affordable Prescription Drugs Act
S. 787, Telehealth Innovation and Improvement Act
S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Congressional Budget Office (CBO), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Grealy |
|
|
|
Debbie |
Witchey |
|
|
|
Michael |
Freeman |
|
|
|
Tina |
Grande |
|
|
|
Amanda |
Uherek |
|
|
|
Christopher |
Adamec |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |